UGT1A1 and triple-negative breast carcinoma: <b>Background:</b> The <i>UGT1A1</i> gene is associated with the toxicity caused by SN38, the cytotoxic component of Sacituzumab govitecan (SG) used in the treatment of metastatic triple-negative breast cancer (mTNBC), among other approved indications.